Physician profile
Casey Morehead
NPI 1881161743
$1,602.37
in general payments reported to CMS, 2019-2025
16 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $224 · 2023: $331 · 2024: $414 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $395.79 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $266.32 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.03 | 2021-2025 | Jardiance |
| Pfizer INC. | $154.15 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $103.22 | 2022-2024 | Camzyos, Eliquis |
| Amgen INC. | $102.12 | 2021-2023 | Repatha |
| United Therapeutics Corporation | $71.92 | 2022-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $64.82 | 2023-2025 | Verquvo, Keytruda |
| Boston Scientific Corporation | $58.19 | 2024 | Watchman Access System |
| Novo Nordisk INC | $39.64 | 2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $37.58 | 2023 | Inpefa |
| Janssen Pharmaceuticals, INC | $32.79 | 2021 | |
| Ethicon US, LLC | $31.70 | 2025 | Prolene, Vistaseal, Surgicel Nu-Knit |
| Abiomed | $30.12 | 2025 | |
| Atricure, INC. | $17.73 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Morehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.